Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$67.10
neg -0.40
-0.59%
Today's Range: 66.80 - 67.48 | GILD Avg Daily Volume: 10,591,700
Last Update: 03/28/17 - 4:00 PM EDT
Volume: 8,504,800
YTD Performance: -5.74%
Open: $67.45
Previous Close: $67.50
52 Week Range: $77.92 - $120.37
Oustanding Shares: 1,307,066,900
Market Cap: 88,240,086,419
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 11 11 12
Moderate Buy 1 1 1 1
Hold 9 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.95 1.85 1.85 1.81
Latest Dividend: 0.52
Latest Dividend Yield: 3.08%
Dividend Ex-Date: 03/14/17
Price Earnings Ratio: 6.79
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
6.79 6.80 30.30
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-8.45% -26.08% -5.48%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.90 1.70 0.39
Net Income -25.50 3.40 0.63
EPS -16.50 4.00 0.70
Earnings for GILD:
EBITDA 18.79B
Revenue 30.39B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $2.15 $2.09 $8.00 $7.62
Number of Analysts 7 6 8 3
High Estimate $2.30 $2.22 $8.59 $8.40
Low Estimate $1.98 $1.99 $7.32 $6.80
Prior Year $2.98 $3.03 $11.37 $8.00
Growth Rate (Year over Year) -27.85% -30.97% -29.64% -4.71%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Mar 27, 2017 | 5:15 PM EDT
For the first time in six years the DJIA fell for the eighth consecutive day. That said the Nasdaq has risen in ten of the last thirteen trading sessions as Donald Trump may be making volatility and uncertainty great again. (For that divergence and other reasons, in "Its All Relative" I like the long [SPDR S&P 500 ETF Trust] (SPY) /short [PowerShares QQQ Trust, Series 1 (ETF)] (QQQ) pairs trade). 
RMPIA
By

Doug Kass

 | Mar 23, 2017 | 3:41 PM EDT
FEB 27, 2017 ' 3:13 PM EST
RMPIA
By

Doug Kass

 | Mar 21, 2017 | 5:47 PM EDT
Risk happens fast. 
RMPIA
By

Doug Kass

 | Mar 20, 2017 | 3:26 PM EDT
James Comey has the market comatose. 
RMPIA
By

Doug Kass

 | Mar 13, 2017 | 12:47 PM EDT
Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (XLV) (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. Last year more than $18 billion was redeemed out of the healthcare ETFs, according to Morningstar. However there are some technical signposts that the two-year period of underperformance might be ending, as a basing seems likely. Look at the chart and note the recent higher high.
RMPIA
By

Bret Jensen

 | Mar 10, 2017 | 11:30 AM EST
Why the name is sagging, and what it will take to spur the sector higher.
RMPIA
By

John Reese

 | Mar 10, 2017 | 8:00 AM EST
Taking from Ben Graham's playbook, this handful of stocks have reasonable valuations in an extended market.
RMPIA
By

Doug Kass

 | Mar 9, 2017 | 3:57 PM EST
This is a great invite, "Wall Street Goes to Washington," in which legendary journalist Michael Wolff will sit down with my pal, The Mooch! And it's free! 
RMPIA
By

Doug Kass

 | Mar 8, 2017 | 3:59 PM EST
 
RMPIA
By

Doug Kass

 | Mar 7, 2017 | 2:36 PM EST
 Nice move off of the lows for Allergan (AGN) . (More than +$3 for the homegamers!) My Generational Bottom in Bond Yields (last July) looks very much intact. Two basis points higher in yield today Today's three-year US note auction was soft. This is not surprising as historically it is quite sensitive to expectations of Fed policy. At 1.63% yield, it was above the when-issued market, the bid to cover (2.74) was below the one year average of 2.80 and dealers got stuck with 42% of the auction (vs. 12-month average of 39%). The yield is the highest in seven years. Let's begin to focus on high yield bonds -- the space is starting to lose steam. (If you are in Blackstone/GSO Strategic Credit Fund (BGB) , reconsider the position). Let's also keep an eye on the S&P (cash) (^GSPC) level of 2363. That's last Tuesday's close, the day before the President's speech to Congress that everyone got excited about... but then, arguably, has been diluted by weekend and weekday tweets. The Russell 2000 RUX and the Transportation Indices have already given back that rally. The DJIA (DIA)  is still 115 points above and the Nasdaq (^IXIC) is 23 points above that level. Again, the market "action" seems to be different than over the last two months. Gold continues its schmeissing, for the sixth day in a row (and since we sold SPDR Gold Trust (GLD) above $119). Phew! But I would note, leveraged junior gold mining ETFs [Dx Dl Jr Gld Min 3X (JNUG)  and [Market Vectors Junior Gold Miners ETF (GDXJ)  are holding up -- so I wouldn't be surprised if a reversal (higher) is imminent. GLD is within $1 of my correction target! Broad based decline in agricultural commodities today - me no likey. And I would continue to avoid fertilizers - they're crap (and the commodity price recovery is far away) Retail stocks? Fuhgettaboutit! Non playable. President Trump put a smackdown on pharma and biotech this morning. Gilead Sciences (GILD) is still a value trap. Share price action in VRX, CMG - seem to be exclamation points to the notion of "Peak Ackman." FANG battling -- but my guess they are ready to be defanged. SNAP's (SNAP) 10% drop is causing collateral damage to Twitter (TWTR)  -- and I am adding more aggressively. Next week, "Three Steps and a Stumble?" I have added to ProShares Trust UltraPro Short QQQ ETF  (SQQQ) and ProShares UltraShort S&P500 (SDS) today -- further raising my net short exposure back up.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.